List of insiders holdings for HOOKIPA Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | GILEAD SCIENCES INC. 10% Owner |
2023-12-22 16:18:56 | 18,759,465 0 |
18,759,465 | Form 13G |
| 2 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN Former 10% owner |
2024-06-14 18:52:27 | 9,813,151 0 |
9,813,151 | Form 13D |
| 3 | Redmile Group LLC Green Jeremy 10% Owner |
2024-02-14 16:26:22 | 1,063,769 0 |
1,063,769 | Form 13G |
| 4 | Aldag Jorn Chief Executive Officer |
2024-04-17 16:15:27 | 971,400 0 |
971,400 | Form 4 |
| 5 | Kandera Reinhard Chief Financial Officer |
2024-04-17 16:15:19 | 406,200 0 |
406,200 | Form 4 |
| 6 | Orlinger Klaus Chief Scientific Officer |
2024-04-17 16:15:29 | 367,300 0 |
367,300 | Form 4 |
| 7 | Necina Roman Chief Operations Officer |
2024-04-17 16:15:11 | 367,300 0 |
367,300 | Form 4 |
| 8 | SOFINNOVA CAPITAL VI FCPR Sofinnova Partners SAS 10% Owner |
2025-02-14 16:25:29 | 314,259 0 |
314,259 | Form 13D |
| 9 | Winderlich Mark Chief Development Officer |
2024-04-17 16:15:25 | 300,000 0 |
300,000 | Form 4 |
| 10 | Baker Christine D. Chief Operating Officer |
2023-04-18 19:47:32 | 275,800 0 |
275,800 | Form 4 |
| 11 | Schlienger Katia Chief Medical Officer |
2023-04-18 19:48:30 | 184,000 0 |
184,000 | Form 4 |
| 12 | Pinschewer David Chief Scientific Officer |
2019-04-24 18:14:30 | 116,416 0 |
116,416 | Form 4 |
| 13 | Peters Malte Chief Executive Officer |
2024-07-24 16:17:16 | 108,695 0 |
108,695 | Form 4 |
| 14 | van de Winkel Jan Director |
2024-06-18 16:15:32 | 98,000 0 |
98,000 | Form 4 |
| 15 | Matushansky Igor Chief Medical Officer |
2022-07-01 16:11:01 | 92,950 0 |
92,950 | Form 4 |
| 16 | Coelho Mary Theresa EVP and CFO |
2024-07-24 16:18:15 | 69,875 0 |
69,875 | Form 4 |
| 17 | Reilly Timothy P. Director |
2024-06-18 16:15:15 | 49,000 0 |
49,000 | Form 4 |
| 18 | O'Neill Julie Director |
2024-06-18 16:15:21 | 49,000 0 |
49,000 | Form 4 |
| 19 | Kaufman David Ross Director |
2024-06-18 16:15:32 | 49,000 0 |
49,000 | Form 4 |
| 20 | Kelly Michael Aaron Director |
2022-07-01 16:09:41 | 20,000 0 |
20,000 | Form 4 |
| 21 | Lilja Anders Sr. VP, Technical Development |
2020-01-27 16:52:34 | 13,098 0 |
13,098 | Form 4 |
| 22 | Cassidy Sean A Director |
2024-07-24 16:16:22 | 9,800 0 |
9,800 | Form 4 |
| 23 | Soria Jean-Charles Director |
2021-06-04 20:37:46 | 9,600 0 |
9,600 | Form 4 |
| 24 | Lengauer Christoph Director |
2021-06-04 20:35:41 | 9,600 0 |
9,600 | Form 4 |
| 25 | van Deventer Sander Director |
2020-10-23 16:03:48 | 2,485 0 |
2,485 | Form 4 |
| 26 | Forbion Capital Fund II Cooperatief U.A. 10% Owner |
2022-02-11 09:18:59 | 966 0 |
966 | Form 13G |
| 27 | Seghezzi Graziano Director |
2021-06-14 16:31:18 | 0 0 |
0 | Form 4/A |